<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.1: Hierarchy of Evidence in Metabolic Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Research & Evidence */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üî¨';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dbeafe 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        /* Statistics Highlight */
        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
            background: #eff6ff;
            padding: 2px 6px;
            border-radius: 4px;
            border-bottom: 2px solid #3b82f6;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            padding: 16px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #f1f5f9;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        tr:nth-child(even) {
            background: #f8fafc;
        }

        /* Principle Cards */
        .principle-card {
            background: white;
            border-left: 5px solid #3b82f6;
            padding: 24px 28px;
            margin-bottom: 18px;
            border-radius: 0 14px 14px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
        }

        .principle-title {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 8px;
            display: block;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-size: 14px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e3a8a;
            margin-bottom: 15px;
        }

        .references-list {
            list-style: none;
            padding: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        .footer-brand {
            text-align: center;
            padding: 40px 0;
            color: #94a3b8;
            font-size: 12px;
            letter-spacing: 1px;
            text-transform: uppercase;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 1: Hierarchy of Evidence in Metabolic Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pyramid"><span class="section-num">1</span>The Evidence Pyramid</a></li>
                <li><a href="#risk"><span class="section-num">2</span>Absolute vs. Relative Risk</a></li>
                <li><a href="#statistics"><span class="section-num">3</span>Significance vs. Relevance</a></li>
                <li><a href="#bias"><span class="section-num">4</span>Identifying Industry Bias</a></li>
                <li><a href="#n-of-1"><span class="section-num">5</span>The Power of N-of-1 Trials</a></li>
                <li><a href="#application"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Navigate the hierarchy of scientific evidence from mechanistic studies to meta-analyses.</li>
                <li>Calculate the difference between absolute and relative risk in clinical trials.</li>
                <li>Differentiate between statistical significance (p-value) and clinical impact (effect size).</li>
                <li>Critically evaluate funding sources and potential conflicts of interest in diabetes research.</li>
                <li>Design N-of-1 protocols to bridge population data with individual client results.</li>
            </ul>
        </div>

        <h2 id="pyramid">1. The Hierarchy of Evidence: Separating Signal from Noise</h2>
        <p>As a Diabetes & Blood Sugar Coach, you are constantly bombarded with headlines: <i>"New Study Shows Coffee Reverses Insulin Resistance"</i> or <i>"Keto Diet Linked to Heart Disease."</i> To maintain the integrity of the <span class="highlight">S.T.A.B.L.E. Method‚Ñ¢</span>, you must be able to categorize these claims within the hierarchy of evidence.</p>
        
        <p>The hierarchy is a tool for ranking the relative strength of results obtained from scientific research. Not all data is created equal. A study on 12 mice in a laboratory (mechanistic/in vitro) provides valuable pathways for future research but should never dictate a human client's carbohydrate threshold.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Evidence Level</th>
                        <th>Type of Study</th>
                        <th>Key Strength</th>
                        <th>Major Limitation</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Level 1 (Top)</strong></td>
                        <td>Systematic Reviews / Meta-Analyses</td>
                        <td>Highest statistical power; reduces bias of single studies.</td>
                        <td>"Garbage in, garbage out" (poor primary studies lead to poor reviews).</td>
                    </tr>
                    <tr>
                        <td><strong>Level 2</strong></td>
                        <td>Randomized Controlled Trials (RCTs)</td>
                        <td>Can establish <strong>causation</strong>; gold standard for interventions.</td>
                        <td>Expensive; often short duration; limited "real world" applicability.</td>
                    </tr>
                    <tr>
                        <td><strong>Level 3</strong></td>
                        <td>Cohort Studies (Prospective)</td>
                        <td>Follows large populations over decades; identifies correlations.</td>
                        <td><strong>Correlation is not causation</strong>; healthy user bias.</td>
                    </tr>
                    <tr>
                        <td><strong>Level 4</strong></td>
                        <td>Case-Control / Case Series</td>
                        <td>Useful for rare conditions or new observations.</td>
                        <td>Small sample sizes; no control group.</td>
                    </tr>
                    <tr>
                        <td><strong>Level 5 (Base)</strong></td>
                        <td>Animal Research / Expert Opinion</td>
                        <td>Explains biological mechanisms.</td>
                        <td>Metabolic pathways in rats often fail to translate to humans.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="risk">2. Interpreting the "Miracle": Absolute vs. Relative Risk</h2>
        <p>One of the most common ways research is "spun" for public consumption is through the use of <span class="highlight">Relative Risk (RR)</span> instead of <span class="highlight">Absolute Risk (AR)</span>. Understanding this distinction is vital when discussing the efficacy of medications like Metformin or GLP-1 agonists with your clients.</p>

        <div class="principle-card">
            <span class="principle-title">The Math of Risk:</span>
            <p>Imagine a study of 2,000 people. 1,000 take a drug, 1,000 take a placebo. Over 5 years:</p>
            <ul>
                <li>Placebo Group: 2 out of 1,000 develop diabetic retinopathy (0.2% AR).</li>
                <li>Drug Group: 1 out of 1,000 develops diabetic retinopathy (0.1% AR).</li>
            </ul>
            <p>The <strong>Relative Risk Reduction</strong> is 50% (1 is half of 2). The headline will read: <i>"New Drug Cuts Risk of Blindness by 50%!"</i> However, the <strong>Absolute Risk Reduction</strong> is only 0.1%. You would need to treat 1,000 people to prevent a single case of blindness (Number Needed to Treat, or NNT).</p>
        </div>

        <p>In the landmark <span class="stat-highlight">Diabetes Prevention Program (DPP) study (n=3,234)</span>, lifestyle intervention reduced the incidence of Type 2 Diabetes by <span class="stat-highlight">58%</span> relative to placebo, while Metformin reduced it by <span class="stat-highlight">31%</span>. However, when we look at absolute numbers, the lifestyle group had an incidence of 4.8 cases per 100 person-years compared to 11.0 in the placebo group‚Äîa massive absolute difference that underscores the power of the lifestyle interventions you coach.</p>

        <h2 id="statistics">3. Statistical Significance vs. Clinical Relevance</h2>
        <p>A result is "statistically significant" if the <strong>p-value</strong> is typically less than 0.05. This simply means the result is unlikely to have occurred by chance. However, <span class="highlight">statistical significance does not equal clinical importance</span>.</p>

        <p>Consider a meta-analysis of a new fiber supplement that finds a "statistically significant" reduction in HbA1c of <span class="stat-highlight">0.1%</span> (p=0.04). While the math says the reduction is real, a 0.1% drop in HbA1c is clinically negligible for a client with an HbA1c of 9.5%. This is where <strong>Effect Size (Cohen's d)</strong> comes in.</p>

        <div class="principle-card">
            <span class="principle-title">Evaluating Effect Size:</span>
            <ul>
                <li><strong>Small Effect (d = 0.2):</strong> Might be significant in a study of 10,000 people, but won't change your client's life.</li>
                <li><strong>Medium Effect (d = 0.5):</strong> Noticeable change in metabolic markers.</li>
                <li><strong>Large Effect (d = 0.8+):</strong> Transformative results (e.g., the impact of resistance training on GLUT4 translocation).</li>
            </ul>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study 1: The Headline Trap</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Interpreting pharmacological claims</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James, 54</h4>
                        <p>Prediabetes (HbA1c 6.2%), high health anxiety.</p>
                    </div>
                </div>
                <p>James arrives at a session excited about a news article claiming a new "super-supplement" reduces the risk of progressing to T2D by 40%. He wants to stop his S.T.A.B.L.E. walking protocol and take the pill instead.</p>
                <p><strong>The Investigation:</strong> You find the primary study. It was a 2-year trial where 5% of the placebo group progressed to T2D, and 3% of the supplement group progressed.
                <ul>
                    <li><strong>Relative Risk Reduction:</strong> (5-3)/5 = 40% (The headline).</li>
                    <li><strong>Absolute Risk Reduction:</strong> 5% - 3% = 2%.</li>
                    <li><strong>NNT:</strong> 1/0.02 = 50. (You must treat 50 people for 2 years to prevent one case).</li>
                </ul>
                </p>
                <p><strong>Outcome:</strong> By explaining the absolute risk, James realized the "40%" was misleading. You compared this to the DPP data (58% relative reduction with a much higher absolute impact), reinforcing his commitment to lifestyle change.</p>
            </div>
        </div>

        <h2 id="bias">4. Identifying Industry Bias and Funding Sources</h2>
        <p>In nutritional epidemiology, industry funding is a significant confounder. A 2013 systematic review found that research funded by the food industry was <span class="stat-highlight">five times more likely</span> to find no association between sugar-sweetened beverages and weight gain compared to studies with no industry ties.</p>

        <p>When reviewing a study, always check the "Conflicts of Interest" or "Funding" section. Ask yourself:</p>
        <ul class="content-list">
            <li>Did the "Dairy Council" fund the study on the benefits of cheese for insulin sensitivity?</li>
            <li>Was the trial on a new SGLT2 inhibitor designed and analyzed by the pharmaceutical company that owns the patent?</li>
            <li><strong>The "Healthy User Bias":</strong> Do people who eat more fiber also exercise more, smoke less, and have higher socioeconomic status? Many observational studies fail to fully adjust for these "lifestyle clusters."</li>
        </ul>

        <h2 id="n-of-1">5. Bridging the Gap: The Role of N-of-1 Trials</h2>
        <p>While meta-analyses tell us what works for the <i>average</i> person, your client is not an average. They are a unique biological entity. The <span class="highlight">N-of-1 trial</span> is a single-subject clinical trial where the client serves as both the intervention and the control group.</p>

        <p>This is where the S.T.A.B.L.E. coach excels. By using Continuous Glucose Monitors (CGMs), we can move beyond population data to <strong>Precision Coaching</strong>.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üß™</div>
                <div>
                    <p class="box-label">Case Study 2: The N-of-1 Protocol</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Validating personal response</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">SM</div>
                    <div class="patient-info">
                        <h4>Sarah, 41</h4>
                        <p>Type 2 Diabetes, curious about "Oatmeal vs. Eggs" for breakfast.</p>
                    </div>
                </div>
                <p>Population data (Level 1 evidence) suggests whole-grain oats are "heart-healthy" and beneficial for diabetics due to beta-glucan fiber. However, Sarah reports feeling lethargic after her morning porridge.</p>
                <p><strong>The N-of-1 Design:</strong>
                <ol>
                    <li><strong>Days 1-3:</strong> Standardized oatmeal breakfast (Control).</li>
                    <li><strong>Days 4-6:</strong> Standardized 3-egg omelet with spinach (Intervention).</li>
                    <li><strong>Metrics:</strong> Post-prandial glucose at 1 and 2 hours via CGM.</li>
                </ol>
                </p>
                <p><strong>Results:</strong> Sarah's glucose peaked at 195 mg/dL with oatmeal but stayed under 120 mg/dL with eggs. Despite the "Level 1" general recommendation, the N-of-1 trial proved that for Sarah‚Äôs specific microbiome and insulin sensitivity, the oatmeal was a metabolic disruptor.</p>
            </div>
        </div>

        <h2 id="application">6. Practical Application: How to Read a Paper</h2>
        <p>When you encounter a new study, use the following "Coach's Filter":</p>
        
        <div class="principle-card">
            <span class="principle-title">The Coach's Filter:</span>
            <ul>
                <li><strong>Sample Size (n):</strong> Was it 10 people or 10,000? Small studies are prone to outliers.</li>
                <li><strong>Duration:</strong> Did they measure HbA1c over 2 weeks (useless) or 6 months (meaningful)?</li>
                <li><strong>Endpoint:</strong> Did they measure a "surrogate marker" (e.g., slightly lower LDL) or a "hard endpoint" (e.g., fewer heart attacks)?</li>
                <li><strong>Comparison:</strong> Did they compare the intervention to a "standard of care" or to a "do-nothing" placebo?</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of evidence-based coaching.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A study claims that a new exercise protocol reduces the relative risk of insulin resistance by 50%. If the original risk was 4% and the new risk is 2%, what is the Absolute Risk Reduction (ARR)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">The ARR is 2% (4% - 2% = 2%). While "50% reduction" sounds massive, the actual absolute benefit to the client is a 2% change in probability.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why might a meta-analysis on the "Low Carb Diet" show conflicting results compared to an N-of-1 trial with your specific client?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">Meta-analyses average out the responses of thousands of people. Factors like individual microbiome composition, genetic SNPs (like TCF7L2), and current muscle mass create high inter-individual variability that population averages cannot capture.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Hierarchy Matters:</strong> Always look for Meta-Analyses and RCTs first, but don't ignore the biological mechanisms found in lower-level research.</li>
                <li><strong>Question the "Spin":</strong> Always convert relative risk percentages into absolute risk to understand the real-world impact.</li>
                <li><strong>Significance vs. Size:</strong> A p-value tells you if a result is real; an effect size tells you if it's important.</li>
                <li><strong>Personalize with N-of-1:</strong> Use population data as a starting point, but use individual biofeedback (CGM, labs) to finalize the intervention.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Knowler WC, et al. (2002). "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin." <i>New England Journal of Medicine</i>.</li>
                <li>Guyatt GH, et al. (2000). "Users' Guides to the Medical Literature: XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care." <i>JAMA</i>.</li>
                <li>Ioannidis JP. (2005). "Why most published research findings are false." <i>PLoS Medicine</i>.</li>
                <li>Liao Y, et al. (2021). "Effect of diet and exercise on glycemic control in adults with type 2 diabetes: A meta-analysis of randomized controlled trials." <i>Journal of Diabetes Research</i>.</li>
                <li>Schork NJ. (2015). "Personalized medicine: Time for one-person trials." <i>Nature</i>.</li>
                <li>Bes-Rastrollo M, et al. (2013). "Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: A systematic review of systematic reviews." <i>PLoS Medicine</i>.</li>
            </ul>
        </div>

        <div class="footer-brand">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" style="max-width:120px; opacity:0.6; margin-bottom:10px;"><br>
            Diabetes & Blood Sugar Coach Certification<br>
            &copy; 2024 AccrediPro Academy. All Rights Reserved.
        </div>
    </div>
</body>

</html>